ER-positive Archives - European Biotechnology Magazine

Tag Archive for: ER-positive

Roche presents details on breast cancer pill giredestrant

Roche has unveiled detailed data for its oral selective estrogen receptor degrader (SERD), giredestrant, at the 2025 San Antonio Breast Cancer Symposium.

12 December 2025

Roche presents details on breast cancer pill giredestrant

Ipsen withdraws cancer drug following safety concer...

A new departure: BioNTech’s founders step aside �...

Roche breast cancer drug falls short of expectation...

Solutions-Based Thinking: BioDlink’s Model for Successful CDMO Partnerships

Stay up to date every week with the european biotechnology newsletter.

Stay up to date every week with the european biotechnology newsletter.

Tag Archive for: ER-positive